🔗 Share this article

An underground economy for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Investigational Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to message these profiles directly for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with thousands of members share comparison photos, injection guides and claims of rapid British shipping. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Professionals Express Worries

However, doctors and chemists have cautions that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could result in individuals administering products of uncertain source.

Several professionals said the popularity for the experimental drug could be connected to the rising cost of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, prosecution or prison.

Service Reaction and Content Elimination

According to TikTok, the service has removed violative content and banned associated keywords and search suggestions. The company stated it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.

Digital Trading Operations

Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately brings up groups with thousands of members, populated with images of weight loss, glowing reviews and step-by-step instructions for mixing or injecting at home.

After moments of joining one group, a vendor shared WhatsApp details, where most purchases occur. The seller sent an guidebook and promised delivery within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. Not one asked about weight, medical conditions or past usage.

Item Details and Pricing

Within these groups, posts show black plastic packages with postal service labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at home with purified liquid, or pre-filled pens usually priced at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A representative for the messaging service stated it actively monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they can’t verify. Even if the science behind this drug is valid, these digital versions may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has previously encountered patients injured by personal administration from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These materials could be impure or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose patients to possibly serious health risks”.